X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8) 8
mutation (7) 7
index medicus (6) 6
lung neoplasms - genetics (6) 6
oncology (6) 6
egfr mutations (4) 4
gefitinib (4) 4
adult (3) 3
aged (3) 3
aged, 80 and over (3) 3
base sequence (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
case-control studies (3) 3
cell lung-cancer (3) 3
dna mutational analysis (3) 3
erbb receptors - genetics (3) 3
exons (3) 3
female (3) 3
high-throughput nucleotide sequencing (3) 3
lung cancer (3) 3
lung neoplasms - drug therapy (3) 3
middle aged (3) 3
molecular sequence data (3) 3
prognosis (3) 3
protein kinase inhibitors - therapeutic use (3) 3
treatment outcome (3) 3
tumors (3) 3
adenocarcinoma - genetics (2) 2
aging (2) 2
biomarkers, tumor - genetics (2) 2
breast cancer (2) 2
cancer (2) 2
carcinoma, non-small-cell lung - blood (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
chemotherapy (2) 2
deoxyribonucleic acid (2) 2
deoxyribonucleic acid--dna (2) 2
dna (2) 2
epidermal growth factor receptors (2) 2
erlotinib (2) 2
erlotinib hydrochloride (2) 2
expression (2) 2
genetic aspects (2) 2
genetic testing (2) 2
growth-factor-receptor (2) 2
immunohistochemistry (2) 2
kinases (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - blood (2) 2
lung neoplasms - enzymology (2) 2
lung neoplasms - pathology (2) 2
male (2) 2
medicine (2) 2
multidisciplinary sciences (2) 2
neoplasms (2) 2
non-small cell lung carcinoma (2) 2
polymorphism, single-stranded conformational (2) 2
quinazolines - therapeutic use (2) 2
receptor, epidermal growth factor - genetics (2) 2
research article (2) 2
respiratory tract diseases (2) 2
science (2) 2
therapy (2) 2
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma of lung (1) 1
adolescent (1) 1
amino acid sequence (1) 1
amplification (1) 1
analysis (1) 1
antibodies (1) 1
antineoplastic agents - therapeutic use (1) 1
antitumor efficacy (1) 1
biology (1) 1
biology and life sciences (1) 1
biomarkers, tumor - blood (1) 1
biopsy (1) 1
blood (1) 1
breast neoplasms - diagnosis (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - metabolism (1) 1
breast-cancer (1) 1
bronchoalveolar lavage fluid - chemistry (1) 1
c-met (1) 1
cancer detection and diagnosis (1) 1
cancer genetics (1) 1
cancer therapies (1) 1
cancers and neoplasms (1) 1
carcinoma - diagnosis (1) 1
carcinoma - genetics (1) 1
carcinoma - metabolism (1) 1
carcinoma, non-small-cell lung - diagnosis (1) 1
carcinoma, non-small-cell lung - enzymology (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
carcinoma, non-small-cell lung - surgery (1) 1
care and treatment (1) 1
catalytic domain (1) 1
cell-growth (1) 1
cep-751 kt-6587 (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 10, pp. 1667 - 1674
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2014, Volume 9, Issue 8, p. e103883
Introduction: Assessment of EGFR mutation in non-small cell lung cancer (NSCLC) patients is mandatory for optimization of pharmacologic treatment. In this... 
BREAST-CANCER | MOLECULAR CHARACTERIZATION | SURVIVAL | THERAPY | DNA | MULTIDISCIPLINARY SCIENCES | PROGRESSION-FREE | FACTOR-RECEPTOR MUTATIONS | DISCORDANCE | EXPRESSION | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Neoplastic Cells, Circulating - pathology | Exons | Humans | Molecular Sequence Data | Neoplastic Cells, Circulating - metabolism | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Case-Control Studies | Base Sequence | Sensitivity and Specificity | Carcinoma, Non-Small-Cell Lung - pathology | Gene Expression | Biomarkers, Tumor - blood | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Carcinoma, Non-Small-Cell Lung - blood | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Lung Neoplasms - blood | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Lung Neoplasms - diagnosis | Care and treatment | Genetic aspects | Lung cancer, Non-small cell | Analysis | Tumors | Lung cancer | Medical services | Oncology | Metastasis | Kinases | Cancer therapies | Nuclei | Blood | Optimization | Aging | Deoxyribonucleic acid--DNA | Sequences | Epidermal growth factor receptors | Tumor cells | Non-small cell lung carcinoma | Breast cancer | Pharmacology | Real time | Patients | Medicine | Chemotherapy | Hospitals | Biopsy | Experimental design | Diagnostic software | Diagnostic systems | Prostate cancer | Cancer | Deoxyribonucleic acid
Journal Article
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2007, Volume 13, Issue 20, pp. 6064 - 6069
PURPOSE: In breast cancer, the PIK3CA gene is frequently mutated at "hotspots" in exons 9 and 20, corresponding to the helical and kinase domains,... 
Journal Article
Neoplasia (New York, N.Y.), ISSN 1522-8002, 10/2009, Volume 11, Issue 10, pp. 1084 - 1092
Mutations inducing resistance to anti-epidermal growth factor receptor (EGFR) therapy may have a clinical impact even if present in minor cell clones which... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.